Great talk of Robin Chaux at the 2023 PAGE meeting on new methodological approach for meta analysis of population PK model !
@Sainbiose_Lab @ChuSaintEtienne
The dawn of a new era in astronomy has begun as the world gets its first look at the full capabilities of the NASA/ESA/CSA James Webb Space Telescope. The telescope’s first full-colour images & spectroscopic data were released today. Read more here https://t.co/kdD6ew5306 or👇
📣 Doctorants #UJM, vous êtes invités à participer à la première journée des doctorants du Campus Santé Innovations afin de découvrir les travaux de recherche des équipes présentes sur le campus.
🗓 : Jeudi 30 juin, de 9h30 �� 16h
➡ : Programme sur votre portail MyUJM
Nouvelle publication pour l'équipe @EMOPT42 !
Bonne lecture
TNF-α and IL-1β Exposure Modulates the Expression and Functionality of P-Glycoprotein in Intestinal and Renal Barri… https://t.co/kin8Wc7uLz
Lancement du congrès pour l’équipe @EMOPT42 avec Sonia Saïb pour le prix de thèse ! Au programme inflammation et modulation des transporteurs de médicaments @ChuSaintEtienne@Univ_St_Etienne@MedvascC
👏@LudoLafaie for highlighting the challenge of AC therapy in elderly VTE patients
Teamwork from @EMOPT42 and @mmonrealriete, opened way for the individualization of TTT
The impact of advanced age on anticoagulant therapy for acute venous thromboembolism https://t.co/RAih9aL6n4
You have a patient treated with apixaban who needs an invasive procedure ?
You need to estimate the time to reach apixaban concentrations below the threshold of 30 ng/ml ?
Read this new paper of our 1st year PhD student !
@INNOVTE1@MedvascC
https://t.co/Z3FbeVezNJ
#DDI risk assessment is recommended to decide the treatment of #cancer-associated #thrombosis.
But few specific data are available.
Congrats to @LudoLafaie and our @Inserm#SAINBIOSE team for this in-vitro study of DDI risk beetween #TKI and #DOAC
https://t.co/1CN6fNJHDv
New Paper from the team !
Robust real time optimization of unfractionated heparin (UFH) during cardiopulmonary bypass
@EdouardOllier@ChuSaintEtienne
https://t.co/lp5AQjORlN
Paper #2 IPD-NMA: for complex network meta-analyses of clinical trials with time-to-event outcomes using individual data we go for a nice penalised approach (with treatment modifiers and nonproportionality) @Cesp_Inserm@EdouardOllier@GustaveRoussy : https://t.co/mHoMVu5N4Y